The crystal structure of the SIV gp41 ectodomain at 1.47 Å resolution

Journal of Structural Biology

Volumn 126, Issue 2, 1999, Pages 131-144

  Yang, Zhong Ning ^a   Mueser, Timothy C ^a   Kaufman, Joshua ^a   Stahl, Stephen J ^a   Wingfield, Paul T ^a   Hyde, C Craig ^a  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

Coiled coil; gp41; HIV; Membrane fusion; Peptide inhibitors; Protein structure; SIV; X ray crystallography

Indexed keywords

GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; VIRUS ENVELOPE PROTEIN;

ARTICLE; CRYSTAL STRUCTURE; HUMAN IMMUNODEFICIENCY VIRUS; MEMBRANE FUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS ENVELOPE;

HUMAN IMMUNODEFICIENCY VIRUS; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0033563698     PISSN: 10478477     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsbi.1999.4116     Document Type: Article

References (57)

1. Baker E. N., Hubbard R. E. Hydrogen bonding in globular proteins. Prog. Biophys. Mol. Biol. 44:1984;97-179.
2. Barney, S. et al., 1996, Synthetic peptides from conserved regions of HIV-1, HIV-2 and SIV fusion proteins are potent antivirals (inhibitors of viral fusion), in, 9th International Conference for Antiviral Research, pp, A57.
3. Beck K., Gambee J. E., Kamawal A., Bachinger H. P. A single amino acid can switch the oligomerization state of the alpha-helical coiled-coil domain of cartilage matrix protein. EMBO J. 16:1997;3767-3777.
4. Blacklow S. C., Lu M., Kim P. S. A trimeric subdomain of the simian immunodeficiency virus envelope glycoprotein. Biochemistry. 34:1995;14955-14962.
5. Brunger, A. 1992, X-PLOR: A system for crystallography and NMR, (Version 3.1), Yale Univ. New Heaven, Connecticut.
6. Brunger A. T. Free R value: Cross-validation in crystallography. Methods Enzymol. 277:1997;366-396.
7. Burton D. R. A vaccine for HIV type 1: The antibody perspective. Proc. Natl. Acad. Sci. USA. 94:1997;10018-10023.
8. Caffrey M. Three dimensional solution structure of the 44 kDa ectodomain of SIV gp41. EMBO J. 17:1998;4572-4584.
9. Caffrey M. Determination of the secondary structure and global topology of the 44 kDa ectodomain of gp41 of the simian immunodeficiency virus by multidimensional nuclear magnetic resonance spectroscopy. J. Mol. Biol. 271:1997;819-826.
10. Cao J. Effects of amino acid changes in the extracellular domain of the human immunodeficiency virus type 1 gp41 envelope glycoprotein. J. Virol. 67:1993;2747-2755.
11. Acta Crystallogr. D. 50:1994;760-763.
12. Chambers P., Pringle C. R., Easton A. J. Heptad repeat sequences are located adjacent to hydrophobic regions in several types of virus fusion glycoproteins. J. Gen. Virol. 71:1990;3075-3080.
13. Chan D. C., Fass D., Berger J. M., Kim P. S. Core structure of gp41 from the HIV envelope glycoprotein. Cell. 89:1997;263-273.
14. Chan D. C., Kim P. S. HIV entry and its inhibition. Cell. 93:1998;681-684.
15. Chen C. H., Matthews T. J., McDanal C. B., Bolognesi D. P., Greenberg M. L. A molecular clasp in the human immunodeficiency virus (HIV) type 1 TM protein determines the anti-HIV activity of gp41 derivatives: Implication for viral fusion. J. Virol. 69:1995;3771-3777.
16. Condra J. H. In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors. Nature. 374:1995;569-571.
17. Cowtan K. An automated procedure for phase improvement by density modification. Joint CCP4 ESF-EACBM Newsl. Protein Crystallogr. 31:1994;34-38.
18. Delwart E. L., Mosialos G., Gilmore T. Retroviral envelope glycoproteins contain a "leucine zipper"-like repeat. AIDS Res. Hum. Retroviruses. 6:1990;703-706.
19. Esnouf R. M. An extensively modified version of Molscript that includes greatly enhanced coloring capabilities. J. Mol. Graph. Model. 15:1997;132-134.
20. Farzan M. Stabilization of human immunodeficiency virus type 1 envelope glycoprotein trimers by disulfide bonds introduced into the gp41 glycoprotein ectodomain. J. Virol. 72:1998;7620-7625.
21. Fass D., Harrison S. C., Kim P. S. Retrovirus envelope domain at 1.7 Å resolution. Nature Struct. Biol. 3:1996;465-469.
22. Freed E. O., Martin M. A. The role of human immunodeficiency virus type 1 envelope glycoproteins in virus infection. J. Biol. Chem. 270:1995;23883-23886.
23. Furey W., Swaminathan S. PHASES-95: A program package for the processing and analyzing diffraction data from macromolecules. Methods Enzymol. 277:1997;590-620.
24. Furuta R. A., Wild C. T., Weng Y., Weiss C. D. Capture of an early fusion-active conformation of HIV-1 gp41. Nature Struct. Biol. 5:1998;276-279.
25. Gallaher W. R., Ball J. M., Garry R. F., Griffin M. C., Montelaro R. C. A general model for the transmembrane proteins of HIV and other retroviruses. AIDS Res. Hum. Retroviruses. 5:1989;431-440.
26. Gonzalez L. Jr., Woolfson D. N., Alber T. Buried polar residues and structural specificity in the GCN4 leucine zipper. Nature Struct. Biol. 3:1996;1011-1018.
27. Hernandez L. D., Hoffman L. R., Wolfsberg T. G., White J. M. Virus-cell and cell-cell fusion. Annu. Rev. Cell Dev. Biol. 12:1996;627-661.
28. Judice J. K. Inhibition of HIV type 1 infectivity by constrained alpha-helical peptides: Implications for the viral fusion mechanism. Proc. Natl. Acad. Sci. USA. 94:1997;13426-13430.
29. Kammerer R. A. Alpha-helical coiled-coil oligomerization domains in extracellular proteins. Matrix Biol. 15:1997;555-565.
30. Kent K. A., Robinson J. Antigenic determinants on HIV-1 envelope glycoproteins: a dickens of a time with oligomer twist. Aids. 10:1996;S107-114.
31. Kleywegt G. J., Jones T. A. Phi/psi-chology: Ramachandran revisited. Structure. 4:1996;1395-1400.
32. Kraulis P. J. MOLSCRIPT: A program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24:1991;946-950.
33. Kwong P. D. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature. 393:1998;648-659.
34. Lu M., Blacklow S. C., Kim P. S. A trimeric structural domain of the HIV-1 transmembrane glycoprotein. Nature Struct. Biol. 2:1995;1075-1082.
35. Lumb K. J., Kim P. S. A buried polar interaction imparts structural uniqueness in a designed heterodimeric coiled coil. Biochemistry. 34:1995;8642-8648.
36. Lupas A. Coiled coils: New structures and new functions. Trends Biochem. Sci. 21:1996;375-382.
37. Malashkevich V. N., Chan D. C., Chutkowski C. T., Kim P. S. Crystal structure of the simian immunodeficiency virus (SIV) gp41 core: Conserved helical interactions underlie the broad inhibitory activity of gp41 peptides. Proc. Natl. Acad. Sci. USA. 95:1998;9134-9139.
38. Matthews T. J., Wild C., Chen C. H., Bolognesi D. P., Greenberg M. L. Structural rearrangements in the transmembrane glycoprotein after receptor binding. Immunol. Rev. 140:1994;93-104.
39. Merritt E. A., Bacon D. J. Raster3D: Photorealistic molecular graphics. Methods Enzymol. 277:1997;505-524.
40. Moore J. P., Sattentau Q. J., Wyatt R., Sodroski J. Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies. J. Virol. 68:1994;469-484.
41. Navaza J. AMoRe: An automated package for molecular replacement. Acta Crystallogr. A. 50:1994;157-163.
42. Otwinowski, Z.1991Maximum likelihood refinement of heavy atom parameters, inWolf, W., Evans, P. R., and Lesile, A. G. W. (Eds.), Proceedings of the CCP4 Study Weekend: Isomorphous Replacement and Anomalous Scattering, pp. 80-86, Daresbury Laboratory, Daresbury, UK.
43. Otwinowski Z., Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276:1997;307-326.
44. Poumbourios P., el Ahmar W., McPhee D. A., Kemp B. E. Determinants of human immunodeficiency virus type 1 envelope glycoprotein oligomeric structure. J. Virol. 69:1995;1209-1218.
45. Poumbourios P., Wilson K. A., Center R. J., El Ahmar W., Kemp B. E. Human immunodeficiency virus type 1 envelope glycoprotein oligomerization requires the gp41 amphipathic alpha-helical/leucine zipper-like sequence. J. Virol. 71:1997;2041-2049.
46. Rabenstein M., Shin Y. K. A peptide from the heptad repeat of human immunodeficiency virus gp41 shows both membrane binding and coiled-coil formation. Biochemistry. 34:1995;13390-13397.
47. Rao Z. Crystal structure of SIV matrix antigen and implications for virus assembly. Nature. 378:1995;743-747.
48. Rimsky L. T., Shugars D. C., Matthews T. J. Determinants of human immunodeficiency virus type 1 resistance to gp41-derived inhibitory peptides. J. Virol. 72:1998;986-993.
49. Sack J. S., Quiocho F. A. CHAIN: A crystallographic modeling program. Methods Enzymol. 277:1997;158-173.
50. Sheldrick G. M., Schneider T. R. SHELXL: High-resolution refinement. Methods Enzymol. 277:1997;319-343.
51. Tan K., Liu J., Wang J., Shen S., Lu M. Atomic structure of a thermostable subdomain of HIV-1 gp41. Proc. Natl. Acad. Sci. USA. 94:1997;12303-12308.
52. Weissenhorn W., Dessen A., Harrison S. C., Skehel J. J., Wiley D. C. Atomic structure of the ectodomain from HIV-1 gp41. Nature. 387:1997;426-430.
53. Wild C., Oas T., McDanal C., Bolognesi D., Matthews T. A synthetic peptide inhibitor of human immunodeficiency virus replication: Correlation between solution structure and viral inhibition. Proc. Natl. Acad. Sci. USA. 89:1992;10537-10541.
54. Wild C. T., Shugars D. C., Greenwell T. K., McDanal C. B., Matthews T. J. Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Proc. Natl. Acad. Sci. USA. 91:1994;9770-9774.
55. Wingfield P. T. The extracellular domain of immunodeficiency virus gp41 protein: expression in Escherichia coli, purification, and crystallization. Protein Sci. 6:1997;1653-1660.
56. Wyatt R. Analysis of the interaction of the human immunodeficiency virus type 1 gp120 envelope glycoprotein with the gp41 transmembrane glycoprotein. J. Virol. 71:1997;9722-9231.
57. Wyatt R. The antigenic structure of the HIV gp120 envelope glycoprotein. Nature. 393:1998;705-711.